Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
about
Current concepts in radiation enteritis and implications for future clinical trials.Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.Side effects of cytokines approved for therapy.Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.A syndrome resembling human systemic sclerosis (scleroderma) in MRL/lpr mice lacking interferon-gamma (IFN-gamma) receptor (MRL/lprgammaR-/-).
P2860
Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@ast
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@en
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@nl
type
label
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@ast
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@en
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@nl
prefLabel
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@ast
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@en
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@nl
P2093
P2860
P356
P1476
Safety and efficacy of recombi ...... eatment of systemic sclerosis.
@en
P2093
Dimitriou I
Moutsopoulos HM
Papiris SA
Tsifetaki N
Vlachoyiannopoulos PG
P2860
P304
P356
10.1136/ARD.55.10.761
P407
P577
1996-10-01T00:00:00Z